The Com. of PA v. The A.G. of the Com. of PA

CourtCommonwealth Court of Pennsylvania
DecidedJanuary 26, 2024
Docket283 M.D. 2022
StatusPublished

This text of The Com. of PA v. The A.G. of the Com. of PA (The Com. of PA v. The A.G. of the Com. of PA) is published on Counsel Stack Legal Research, covering Commonwealth Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Com. of PA v. The A.G. of the Com. of PA, (Pa. Ct. App. 2024).

Opinion

IN THE COMMONWEALTH COURT OF PENNSYLVANIA

The Commonwealth of Pennsylvania, : by and through the Philadelphia District : Attorney, Larry Krasner, and The : Commonwealth of Pennsylvania, by and : through the Allegheny County District : Attorney, Stephen A. Zappala, Jr., : : Petitioners : : v. : No. 283 M.D. 2022 : Argued: October 12, 2022 The Attorney General of the : Commonwealth of Pennsylvania, : McKesson Corp., Cardinal Health, Inc., : AmerisourceBergen Drug Corp., Johnson : & Johnson, Janssen Pharmaceuticals, Inc., : Ortho-McNeil-Janssen Pharmaceuticals, : Inc., and Janssen Pharmaceutica, Inc., : : Respondents :

BEFORE: HONORABLE RENÉE COHN JUBELIRER, President Judge HONORABLE MICHAEL H. WOJCIK, Judge HONORABLE ELLEN CEISLER, Judge HONORABLE LORI A. DUMAS, Judge HONORABLE STACY WALLACE, Judge

OPINION BY JUDGE WOJCIK FILED: January 26, 2024

Before this Court, in our original jurisdiction, are the cross- Applications for Summary Relief (ASRs) filed by the Petitioners, Commonwealth of Pennsylvania, by and through Philadelphia District Attorney, Larry Krasner (DA Krasner), and the Allegheny County District Attorney, Stephen A. Zappala, Jr. (DA Zappala) (collectively, DAs); Respondent Attorney General of the Commonwealth of Pennsylvania (Attorney General); and Respondents McKesson Corp., Cardinal Health, Inc., AmerisourceBergen Drug Corp. (Settling Distributors), and Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica, Inc. (Settling Manufacturers) (collectively, Settling Defendants). In this case of first impression, the parties seek a declaration on the issue of whether the Attorney General has the authority to settle and release claims brought by the DAs under Pennsylvania’s Unfair Trade Practices and Consumer Protection Law (UTPCPL).1 Upon review, we grant summary relief in favor of the Attorney General, deny the relief sought by the DAs, and dismiss the relief sought by Settling Defendants as moot.

I. Background This case involves a dispute of authority regarding the Attorney General’s ability to settle and release claims brought by the DAs under the UTPCPL against manufacturers and distributors of prescription opioid drugs as part of the nationwide settlement with Settling Defendants. On May 17, 2022, the DAs filed a Petition for Review in the Nature of a Complaint for Declaratory and Injunctive Relief (PFR). Therein, the DAs alleged that they filed civil enforcement actions, as authorized by Section 4 of the UTPCPL, 73 P.S. §201-4, in the name of the Commonwealth, against certain manufacturers and distributors of opioid drugs, including Settling Defendants, seeking to hold them accountable for engaging in commercial activities that fueled the deadly opioid

1 Act of December 17, 1968, P.L. 1224, reenacted by the Act of November 24, 1976, P.L. 1166, as amended, 73 P.S. §§201-1 - 201-10. 2 epidemic.2 Therein, the DAs similarly alleged that the manufacturers violated the UTPCPL by using unfair methods of competition and unfair or deceptive acts or practices in the manufacture, sale, and promotion of prescription opioid products, and that the distributors furthered the improper distribution of prescription opioid drugs made and marketed by manufacturers. Both enforcement actions sought injunctive relief and monetary remedies derived from the disgorgement of revenues. See PFR, Exhibits C and D. The DAs were not alone in pursuing legal recourse against opioid manufacturers and distributors. In Pennsylvania, district attorneys from various counties including Berks, Bucks, Chester, Clearfield, Dauphin, Delaware, Erie, Lehigh, Northampton, and Westmoreland, filed similar suits as did other states, territories, and local governments.3 PFR, ¶34. On April 18, 2022, the Attorney General filed two suits on behalf of the Commonwealth in this Court under the UTPCPL, which this Court consolidated. See Commonwealth of Pennsylvania v. Johnson & Johnson (Pa. Cmwlth., Nos. 243 & 244 M.D. 2022, consolidation order filed May 9, 2022). During the pendency of these multiple enforcement actions, the Attorney General, together with attorneys general from other states, negotiated two nationwide settlement agreements (Settlement Agreements) with the Settling

2 DA Krasner filed an amended complaint on November 14, 2018, in the Philadelphia County Court of Common Pleas; DA Zappala filed a complaint on February 3, 2021, in the Allegheny County Court of Common Pleas.

3 Similar complaints were filed against retail pharmacies for their role in the opioid crisis. See, e.g., Commonwealth of Pennsylvania v. RiteAid Corporation (Pa. Cmwlth., No. 215 M.D. 2022). In addition, private parties filed actions under Section 9.2 of the UTPCPL, added by the Act of November 24, 1976, as amended, 73 P.S. §201-9.2. This case, however, does not concern claims against retail pharmacies or any private UTPCPL claim, only claims against the Settling Defendants. 3 Defendants to resolve claims against those defendants for their role in contributing to the opioid crisis.4 The Settling Defendants agreed to pay a total of $26,000,000,000 to the states and their “Subdivisions,” which included $1,000,000,000 for Pennsylvania. In Pennsylvania, 333 of 356 eligible municipal entities voluntarily agreed to join the Settlement Agreements, including all 67 counties, 256 of 277 municipalities, and 10 of 12 district attorneys. The City of Philadelphia and Allegheny County were among the municipalities that joined the Settlement Agreements, but their DAs refused to discontinue their UTPCPL claims. On behalf of the Commonwealth, the Attorney General and Settling Defendants then filed a Joint Motion to Enter Final Consent Judgments with this Court to approve both Settlement Agreements, which this Court entered on July 12, 2022 (Consent Judgments). PFR, Exhibits G and H; see Commonwealth of Pennsylvania v. Johnson & Johnson (Pa. Cmwlth., Nos. 243 & 244 M.D. 2022, filed July 12, 2022). As part of the settlement, the Attorney General, acting on behalf of the Commonwealth, agreed to settle and release all claims against the Settling Defendants, including those previously filed by the DAs. In the Settlement Agreements, the Attorney General represented and warranted that he had “the authority to settle and release” all claims.5 PFR, Exhibit A, Distributor Settlement Agreement at 48, ¶XI(G); Exhibit B, Janssen Settlement Agreement at 17, ¶IV(E). As to whether the Attorney General had such power, the parties agreed that disputes

4 One Settlement Agreement resolved claims against the Settling Manufacturers, identified as “Janssen Settlement Agreement”; the other resolved claims against the Settling Distributors, identified as “Distributor Settlement Agreement.” PFR, Exhibits A & B.

5 This was further confirmed in a memorandum of understanding between the settling parties. See Commonwealth Application for Summary Relief, Exhibit B, ¶2. Therein, the Attorney General agreed to take all necessary steps to secure the dismissal with finality of the released claims, including those of the DAs. Id., ¶6. 4 regarding the Attorney General’s “authority under the state law, including the extent of the authority to release claims” would be resolved in state court. PFR, Exhibit A, Distributor Settlement Agreement at 36, ¶VI(F)(1)(b)(iv); id., Exhibit B, Janssen Settlement Agreement at 44, ¶XII(F)(2)(d). The issue of the Attorney General’s authority is the precise issue now before this Court. By filing the PFR, the DAs seek declaratory and injunctive relief on the basis that the Attorney General lacks the authority to extinguish their UTPCPL claims.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Astoria Federal Savings & Loan Ass'n v. Solimino
501 U.S. 104 (Supreme Court, 1991)
In Re Gross
382 A.2d 116 (Supreme Court of Pennsylvania, 1978)
Gabriel v. O'HARA
534 A.2d 488 (Supreme Court of Pennsylvania, 1987)
Margiotti Appeal
75 A.2d 465 (Supreme Court of Pennsylvania, 1950)
Commonwealth v. Fudeman
152 A.2d 428 (Supreme Court of Pennsylvania, 1959)
Commonwealth v. Carsia
517 A.2d 956 (Supreme Court of Pennsylvania, 1986)
Spahn v. Zoning Board of Adjustment
977 A.2d 1132 (Supreme Court of Pennsylvania, 2009)
O'ROURKE v. Commonwealth
778 A.2d 1194 (Supreme Court of Pennsylvania, 2001)
Matson v. Margiotti
88 A.2d 892 (Supreme Court of Pennsylvania, 1952)
Pruner Estate
136 A.2d 107 (Supreme Court of Pennsylvania, 1957)
Commonwealth v. Schab
383 A.2d 819 (Supreme Court of Pennsylvania, 1978)
In Re Rodriguez
900 A.2d 341 (Supreme Court of Pennsylvania, 2003)
Commonwealth Ex Rel. Minerd v. Margiotti
188 A. 524 (Supreme Court of Pennsylvania, 1936)
Dauphin County Grand Jury Investigation Proceedings
2 A.2d 783 (Supreme Court of Pennsylvania, 1938)
J. Markham v. Thomas W. Wolf
147 A.3d 1259 (Commonwealth Court of Pennsylvania, 2016)
Eleven Eleven Pennsylvania, LLC v. Commonwealth, State Board of Cosmetology
169 A.3d 141 (Commonwealth Court of Pennsylvania, 2017)
Gregory v. Pa. State Police
185 A.3d 1202 (Commonwealth Court of Pennsylvania, 2018)
Commonwealth ex rel. Specter v. Bauer
261 A.2d 573 (Supreme Court of Pennsylvania, 1970)
Commonwealth v. Herman
161 A.3d 194 (Supreme Court of Pennsylvania, 2017)
Driscoll v. Zoning Bd. of Adjustment of Phila.
201 A.3d 265 (Commonwealth Court of Pennsylvania, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
The Com. of PA v. The A.G. of the Com. of PA, Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-com-of-pa-v-the-ag-of-the-com-of-pa-pacommwct-2024.